287 related articles for article (PubMed ID: 29751768)
21. Influence of autoimmune ovarian disease pathogenesis on ZP3 contraceptive vaccine design.
Lou YH; Bagavant H; Ang J; McElveen MF; Thai H; Tung KS
J Reprod Fertil Suppl; 1996; 50():159-63. PubMed ID: 8984179
[TBL] [Abstract][Full Text] [Related]
22. Production of tag-free recombinant fusion protein encompassing promiscuous T cell epitope of tetanus toxoid and dog zona pellucida glycoprotein-3 for contraceptive vaccine development.
Gupta N; Shrestha A; Panda AK; Gupta SK
Mol Biotechnol; 2013 Jul; 54(3):853-62. PubMed ID: 23242635
[TBL] [Abstract][Full Text] [Related]
23. Ovarian function following immunocontraceptive vaccination of mares using native porcine and recombinant zona pellucida vaccines formulated with a non-Freund's adjuvant and anti-GnRH vaccines.
Nolan MB; Bertschinger HJ; Roth R; Crampton M; Martins IS; Fosgate GT; Stout TA; Schulman ML
Theriogenology; 2018 Oct; 120():111-116. PubMed ID: 30099144
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of antibodies against a chimeric synthetic peptide encompassing epitopes of bonnet monkey (Macaca radiata) zona pellucida-1 and zona pellucida-3 glycoproteins to inhibit in vitro human sperm-egg binding.
Sivapurapu N; Hasegawa A; Gahlay GK; Koyama K; Gupta SK
Mol Reprod Dev; 2005 Mar; 70(3):247-54. PubMed ID: 15625695
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in contraceptive vaccine development: a mini-review.
Naz RK; Gupta SK; Gupta JC; Vyas HK; Talwar AG
Hum Reprod; 2005 Dec; 20(12):3271-83. PubMed ID: 16113040
[TBL] [Abstract][Full Text] [Related]
26. Development of mouse-specific contraceptive vaccines: infertility in mice immunized with peptide and polyepitope antigens.
Hardy CM; Clydesdale G; Mobbs KJ
Reproduction; 2004 Oct; 128(4):395-407. PubMed ID: 15454634
[TBL] [Abstract][Full Text] [Related]
27. Intranasal co-delivery with the mouse zona pellucida 3 and GM-CSF expressing constructs enhances humoral immune responses and contraception in mice.
Ma X; Li J; Zhang F
Scand J Immunol; 2012 Dec; 76(6):521-7. PubMed ID: 22924630
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of zona pellucida antigens as potential candidates for immunocontraception.
Paterson M; Wilson MR; van Duin M; Aitken RJ
J Reprod Fertil Suppl; 1996; 50():175-82. PubMed ID: 8984181
[TBL] [Abstract][Full Text] [Related]
29. Zona pellucida glycoproteins: Relevance in fertility and development of contraceptive vaccines.
Gupta SK
Am J Reprod Immunol; 2023 Feb; 89(2):e13535. PubMed ID: 35249246
[TBL] [Abstract][Full Text] [Related]
30. Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats.
Eade JA; Roberston ID; James CM
Reproduction; 2009 Jun; 137(6):913-22. PubMed ID: 19279201
[TBL] [Abstract][Full Text] [Related]
31. A contraceptive peptide vaccine targeting sulfated glycoprotein ZP2 of the mouse zona pellucida.
Sun W; Lou YH; Dean J; Tung KS
Biol Reprod; 1999 Apr; 60(4):900-7. PubMed ID: 10084964
[TBL] [Abstract][Full Text] [Related]
32. Zona pellucida glycoproteins based immunocontraceptive vaccines: strategies for development and their applications.
Gupta SK; Choudhury S; Srivastava N; Ravi C
Indian J Exp Biol; 2003 Jul; 41(7):682-93. PubMed ID: 15255371
[TBL] [Abstract][Full Text] [Related]
33. The effects of GM-CSF and IL-5 as molecular adjuvants on immune responses and contraception induced by mZP3 DNA vaccination.
Ma X; Kadir Z; Li J; Zhang F
Am J Reprod Immunol; 2012 Dec; 68(6):476-85. PubMed ID: 22934542
[TBL] [Abstract][Full Text] [Related]
34. Immunocontraceptive potential of a GnRH receptor-based fusion recombinant protein.
Sandam NP; Prakash D; Thimmareddy P
J Genet Eng Biotechnol; 2021 May; 19(1):63. PubMed ID: 33945047
[TBL] [Abstract][Full Text] [Related]
35. Antifertility effect of active immunization with ZP4 glycoprotein family of porcine zona pellucida in hamsters.
Hasegawa A; Koyama K; Inoue M; Takemura T; Isojima S
J Reprod Immunol; 1992 Aug; 22(2):197-210. PubMed ID: 1501206
[TBL] [Abstract][Full Text] [Related]
36. A zona pellucida 3 peptide vaccine induces antibodies and reversible infertility without ovarian pathology.
Lou Y; Ang J; Thai H; McElveen F; Tung KS
J Immunol; 1995 Sep; 155(5):2715-20. PubMed ID: 7650399
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and contraceptive potential of a human zona pellucida 3 peptide vaccine.
Bagavant H; Fusi FM; Baisch J; Kurth B; David CS; Tung KS
Biol Reprod; 1997 Mar; 56(3):764-70. PubMed ID: 9047023
[TBL] [Abstract][Full Text] [Related]
38. Histology of ovaries of female rabbits immunized with deglycosylated zona pellucida macromolecules of pigs.
Jones GR; Sacco AG; Subramanian MG; Kruger M; Zhang S; Yurewicz EC; Moghissi KS
J Reprod Fertil; 1992 Jul; 95(2):513-25. PubMed ID: 1518006
[TBL] [Abstract][Full Text] [Related]
39. Contraceptive vaccines for the humane control of community cat populations.
Levy JK
Am J Reprod Immunol; 2011 Jul; 66(1):63-70. PubMed ID: 21501281
[TBL] [Abstract][Full Text] [Related]
40. Prior infection with murine cytomegalovirus (MCMV) limits the immunocontraceptive effects of an MCMV vector expressing the mouse zona-pellucida-3 protein.
Gorman S; Lloyd ML; Smith LM; McWhorter AR; Lawson MA; Redwood AJ; Shellam GR
Vaccine; 2008 Jul; 26(31):3860-9. PubMed ID: 18573574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
